Izvoz spreman — 

Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations

The recent discovery of relevant biomarkers has reshaped our approach to therapy selection for patients with non-small cell lung cancer. The unprecedented outcomes demonstrated with tyrosine kinase inhibitors in molecularly defined cohorts of patients has underscored the importance of genetic profil...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncologist
Glavni autori: Levy, Benjamin P., Chioda, Marc D., Herndon, Dana, Longshore, John W., Mohamed, Mohamed, Ou, Sai-Hong Ignatius, Reynolds, Craig, Singh, Jaspal, Wistuba, Ignacio I., Bunn, Paul A., Hirsch, Fred R.
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2015
Teme:
Lung Cancer
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4591939/
https://ncbi.nlm.nih.gov/pubmed/26330460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0114
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items